Search Results (31)
Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| Carpenter, Shannon | Person |
Why?
|
| Current prescription of prophylactic factor infusions and perceived adherence for children and adolescents with haemophilia: a survey of haemophilia healthcare professionals in the United States. | Academic Article |
Why?
|
| Using dried blood spots for variant analysis for patients with haemophilia. | Academic Article |
Why?
|
| Anti-inhibitor coagulant complex prophylaxis in hemophilia with inhibitors. | Academic Article |
Why?
|
| Trends in dedicated care for females with bleeding disorders within U.S. hemophilia treatment centers. | Academic Article |
Why?
|
| Awareness, Care and Treatment In Obesity maNagement to inform Haemophilia Obesity Patient Empowerment (ACTION-TO-HOPE): Results of a survey of US patients with haemophilia and obesity (PwHO) and their partners and caregivers. | Academic Article |
Why?
|
| Hemophilia A | Concept |
Why?
|
| Hemophilia B | Concept |
Why?
|
| A phase IV, multicentre, open-label study of emicizumab prophylaxis in people with haemophilia A with or without FVIII inhibitors undergoing minor surgical procedures. | Academic Article |
Why?
|
| Increased prevalence of inhibitors in Hispanic patients with severe haemophilia A enrolled in the Universal Data Collection database. | Academic Article |
Why?
|
| Prophylactic bypassing agent use before and during immune tolerance induction in patients with haemophilia A and inhibitors to FVIII. | Academic Article |
Why?
|
| The development of pulmonary embolus in patients with haemophilia A and high-titre inhibitors - a case series and review of the literature. | Academic Article |
Why?
|
| Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study | Academic Article |
Why?
|
| A Prospective Observational Study of Antihemophilic Factor (Recombinant) Prophylaxis Related to Physical Activity Levels in Patients with Hemophilia A in the United States (SPACE). | Academic Article |
Why?
|
| Individualized factor IX dosing in two brothers: application of longitudinal pharmacokinetic modelling to optimize therapeutic benefit. | Academic Article |
Why?
|